ANI Acquires Alimera Sciences To Bolster Ophthalmology Portfolio

The Move Reflects ANI’s Ambition To Increase Foothold In Rare Disease

 
• By Adam Zamecnik
  
Illustrative image of a deal
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business